₹ (%)
- NSE
- BSE
Overview
- BSE Code 524414
- NSE Symbol
- ISIN Demat INE744C01029
- Book Value (₹) -14.79
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 17.58
- P/E (TTM) 0.00
- EPS (TTM) 0.00
- Div Yield (%) 0.00
Performance
About Norris Medicines Ltd
Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91.
The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995.
The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups strategic emphasis and marketing strengths worldwide.
Founded | : 1990 |
Managing Director | : Vimal D Shah |
Address | : Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002, |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)